INNOVATIVE BIOLOGICS, INC

Address

INNOVATIVE BIOLOGICS, INC
13455 SUNRISE VALLEY DR, STE 200
HERNDON, VA, 20171 3296

Information

DUNS: 169174146
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. In vivo Testing of S. aureus alpha-Hemolysin Inhibitors

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): We have recently demonstrated that alpha-hemolysin produced by S. aureus plays a key role in the pathogenesis of staphylococcal pneumonia, and identified beta-cycl ...

    SBIRPhase I2009Department of Health and Human Services
  2. Small Molecule Blockers of B. anthracis Toxin

    Amount: $1,953,670.00

    DESCRIPTION (provided by applicant): The results from our SBIR Phase II project demonstrated that ?-cyclodextrin derivatives designed to block the transmembrane channel formed by B. anthracis protecti ...

    SBIRPhase II2009Department of Health and Human Services
  3. Small Molecule Inhibitors of C. perfringens Epsilon-Toxin

    Amount: $741,493.00

    DESCRIPTION (provided by applicant): C. perfringens epsilon-toxin (ETX) is a potential biological weapon included in the list of category B priority agents. The overall goal of this proposal is to ide ...

    SBIRPhase II2008Department of Health and Human Services
  4. Small Molecule Inhibitors of C. perfringens Epsilon-Toxin

    Amount: $99,097.00

    DESCRIPTION (provided by applicant): The overall goal of this SBIR Phase I proposal is to find compounds that inhibit C. perfringens epsilon-toxin action using a novel approach for the inactivation of ...

    SBIRPhase I2007Department of Health and Human Services
  5. Small Molecule Blockers of B. anthracis Toxin

    Amount: $1,273,130.00

    DESCRIPTION (provided by investigator): Results from our SBIR Phase I project demonstrated that beta-cyclodextrin derivatives designed to block the trans-membrane channel formed by B. anthracis protec ...

    SBIRPhase II2004Department of Health and Human Services
  6. SMALL MOLECULE BLOCKERS OF B. ANTHRACIS TOXIN

    Amount: $106,498.00

    DESCRIPTION (provided by applicant): The overall goal of this SBIR proposal is the identification of small molecules capable of blocking the cytotoxic action of Bacillus anthracis lethal toxin by blo ...

    SBIRPhase I2002Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government